Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription


2 BMC Cancer
2 Br J Cancer
4 Cancer
1 Cancer Lett
2 Cancer Res
3 Clin Cancer Res
5 Dis Colon Rectum
8 Eur J Surg Oncol
2 Gastroenterology
3 Hum Pathol
2 Int J Cancer
1 Int J Colorectal Dis
1 Int J Oncol
1 J Clin Oncol
1 J Surg Oncol
2 Oncogene
2 Oncol Rep
3 PLoS One

    BMC Cancer

  1. ZHOU P, Wang C, Hu Z, Chen W, et al
    Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-kappaB/slug/E-cadherin pathway.
    BMC Cancer. 2017;17:813.
    >> Share

  2. BENEDICTO A, Marquez J, Herrero A, Olaso E, et al
    Decreased expression of the beta2 integrin on tumor cells is associated with a reduction in liver metastasis of colorectal cancer in mice.
    BMC Cancer. 2017;17:827.
    >> Share

    Br J Cancer

  3. DOPESO H, Rodrigues P, Bilic J, Bazzocco S, et al
    Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer.
    Br J Cancer. 2017 Dec 5. pii: bjc2017420. doi: 10.1038/bjc.2017.
    >> Share

  4. FLOUD S, Barnes I, Verfurden M, Kuper H, et al
    Disability and participation in breast and bowel cancer screening in England: a large prospective study.
    Br J Cancer. 2017;117:1711-1714.
    >> Share


  5. WHITE A, Joseph D, Rim SH, Johnson CJ, et al
    Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5014-5036.
    >> Share

  6. DESHMUKH AA, Chiao EY, Cantor SB, Stier EA, et al
    Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.31035.
    >> Share

  7. MEROPOL NJ, Feng Y, Grem JL, Mulcahy MF, et al
    Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203).
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.30967.
    >> Share

  8. NIXON NA, Khan OF, Imam H, Tang PA, et al
    Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014.
    Cancer. 2017;123:4672-4679.
    >> Share

    Cancer Lett

  9. FANG Z, Gong C, Yu S, Zhou W, et al
    NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
    Cancer Lett. 2017 Dec 1. pii: S0304-3835(17)30765.
    >> Share

    Cancer Res

  10. HANKEY WC, McIlhatton MA, Ebede K, Kennedy B, et al
    Mutational mechanisms that activate Wnt signaling and predict outcomes in colorectal cancer patients.
    Cancer Res. 2017 Dec 6. pii: 0008-5472.CAN-17-1357.
    >> Share

  11. Correction: miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4.
    Cancer Res. 2017;77:6788.
    >> Share

    Clin Cancer Res

  12. CARNERO A, Lucena-Cacace A, Otero-Albiol D, Jimenez-Garcia MP, et al
    NAMPT is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and resistance to therapy through Sirt1 and PARP.
    Clin Cancer Res. 2017 Dec 4. pii: 1078-0432.CCR-17-2575.
    >> Share

  13. ULINTZ PJ, Greenson JK, Wu R, Fearon ER, et al
    Lymph Node Metastases in Colon Cancer are Polyclonal.
    Clin Cancer Res. 2017 Dec 4. pii: 1078-0432.CCR-17-1425.
    >> Share

  14. BERGER MD, Stintzing S, Heinemann V, Cao S, et al
    A polymorphism within the vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab or FOLFIRI/cetuximab.
    Clin Cancer Res. 2017 Dec 5. pii: 1078-0432.CCR-17-1663.
    >> Share

    Dis Colon Rectum

  15. KELLER DS, Flores Gonzalez JR, Chand M
    Multimodal Use of Fluorescent Imaging in Colorectal Cancer Surgery.
    Dis Colon Rectum. 2018;61:139.
    >> Share

  16. KISHIKI T, Lapin B, Matsuoka H, Watanabe T, et al
    Optimal Surveillance Protocols After Curative Resection in Patients With Stage IV Colorectal Cancer: A Multicenter Retrospective Study.
    Dis Colon Rectum. 2018;61:51-57.
    >> Share

  17. SITLINGER AP, Zafar SY
    With Colorectal Cancer Treatment, Physical Toxicity Is Not the Only Concern.
    Dis Colon Rectum. 2018;61:4-5.
    >> Share

  18. SHARP L, O'Leary E, O'Ceilleachair A, Skally M, et al
    Financial Impact of Colorectal Cancer and Its Consequences: Associations Between Cancer-Related Financial Stress and Strain and Health-Related Quality of Life.
    Dis Colon Rectum. 2018;61:27-35.
    >> Share

  19. ALTHANS AR, Brady JT, Times ML, Keller DS, et al
    Colorectal Cancer Safety Net: Is It Catching Patients Appropriately?
    Dis Colon Rectum. 2018;61:115-123.
    >> Share

    Eur J Surg Oncol

  20. PETZ W, Ribero D, Bertani E, Borin S, et al
    Suprapubic approach for robotic complete mesocolic excision in right colectomy: Oncologic safety and short-term outcomes of an original technique.
    Eur J Surg Oncol. 2017;43:2060-2066.
    >> Share

  21. LEE SH, Lee JL, Kim CW, Lee HI, et al
    Oncologic significance of para-aortic lymph node and inferior mesenteric lymph node metastasis in sigmoid and rectal adenocarcinoma.
    Eur J Surg Oncol. 2017;43:2076-2083.
    >> Share

  22. HELDENS AFJM, Bongers BC, Lenssen AF, Stassen LPS, et al
    The association between performance parameters of physical fitness and postoperative outcomes in patients undergoing colorectal surgery: An evaluation of care data.
    Eur J Surg Oncol. 2017;43:2084-2092.
    >> Share

  23. GASH KJ, Baser O, Kiran RP
    Factors associated with degree of tumour response to neo-adjuvant radiotherapy in rectal cancer and subsequent corresponding outcomes.
    Eur J Surg Oncol. 2017;43:2052-2059.
    >> Share

  24. REHA J, Mukkamalla SKR, Rathore R, Somasundar PS, et al
    Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I-III colon cancer: A validation study using the National Cancer Data Base.
    Eur J Surg Oncol. 2017 Nov 23. pii: S0748-7983(17)30966.
    >> Share

  25. OFFERMANS T, Vogelaar FJ, Aquarius M, Janssen-Heijnen MLG, et al
    Preoperative segmental localization of colorectal carcinoma: CT colonography vs. optical colonoscopy.
    Eur J Surg Oncol. 2017;43:2105-2111.
    >> Share

  26. SIDDIQUI MRS, Shanmuganandan AP, Rasheed S, Tekkis P, et al
    An audit comparing the reporting of staging MRI scans for rectal cancer with the London Cancer Alliance (LCA) guidelines.
    Eur J Surg Oncol. 2017;43:2093-2104.
    >> Share

  27. YOUNG CJ, Zahid A, Choy I, Thompson JF, et al
    Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients.
    Eur J Surg Oncol. 2017;43:2163-2169.
    >> Share


  28. LIU L, Nishihara R, Qian ZR, Tabung FK, et al
    Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.
    Gastroenterology. 2017;153:1517-1530.
    >> Share

  29. LIU X, Wei W, Li X, Shen P, et al
    BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.
    Gastroenterology. 2017;153:1607-1620.
    >> Share

    Hum Pathol

  30. LEE HE, Chandan VS, Lee CT, Wu TT, et al
    Squamoid morules in the pseudoinvasive foci of colonic polyp morphologically mimic invasive carcinoma.
    Hum Pathol. 2017;68:54-60.
    >> Share

  31. VAN DER LINDEN M, Bult P, Nagtegaal ID, Massuger LFAG, et al
    Cervical metastases originating from a primary rectal adenocarcinoma due to a pagetoid spread.
    Hum Pathol. 2017;68:184-188.
    >> Share

  32. LE FLAHEC G, Badic B, Guibourg B, Doucet L, et al
    Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant PD-L1 expression in tumor cells.
    Hum Pathol. 2017 Dec 2. pii: S0046-8177(17)30436.
    >> Share

    Int J Cancer

  33. RAY AL, Berggren KL, Restrepo Cruz S, Gan GN, et al
    Inhibition of MK2 suppresses IL-1beta, IL-6, and TNF-alpha dependent colorectal cancer growth.
    Int J Cancer. 2017 Dec 2. doi: 10.1002/ijc.31191.
    >> Share

  34. SCHWINGSHACKL L, Schwedhelm C, Hoffmann G, Knuppel S, et al
    Food groups and risk of colorectal cancer.
    Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31198.
    >> Share

    Int J Colorectal Dis

  35. ZURLENI T, Cassiano A, Gjoni E, Ballabio A, et al
    Correction to: Surgical and oncological outcomes after complete mesocolic excision in right-sided colon cancer compared with conventional surgery: a retrospective, single-institution study.
    Int J Colorectal Dis. 2017 Dec 7. pii: 10.1007/s00384-017-2936.
    >> Share

    Int J Oncol

  36. OLEJNICZAK A, Szarynska M, Kmiec Z
    In vitro characterization of spheres derived from colorectal cancer cell lines.
    Int J Oncol. 2017 Nov 16. doi: 10.3892/ijo.2017.4206.
    >> Share

    J Clin Oncol

  37. XU J, Kim TW, Shen L, Sriuranpong V, et al
    Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study.
    J Clin Oncol. 2017 Dec 7:JCO2017743245. doi: 10.1200/JCO.2017.74.3245.
    >> Share

    J Surg Oncol

  38. IWAI T, Yamada T, Koizumi M, Shinji S, et al
    Oxaliplatin-induced increase in splenic volume; irreversible change after adjuvant FOLFOX.
    J Surg Oncol. 2017;116:947-953.
    >> Share


  39. LEE JH, Han YS, Yoon YM, Yun CW, et al
    Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1alpha/GP78 axis.
    Oncogene. 2017;36:6555-6567.
    >> Share

  40. HATA AN, Rowley S, Archibald HL, Gomez-Caraballo M, et al
    Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers.
    Oncogene. 2017;36:6581-6591.
    >> Share

    Oncol Rep

  41. ZHAO J, Xu J, Zhang R
    MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Oncol Rep. 2017 Dec 5. doi: 10.3892/or.2017.6135.
    >> Share

  42. CHEN M, Lin M, Wang X
    Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6110.
    >> Share

    PLoS One

  43. HWANG IC, Chang J, Park SM
    Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
    PLoS One. 2017;12:e0189114.
    >> Share

  44. BERRY RS, Xiong MJ, Greenbaum A, Mortaji P, et al
    High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer.
    PLoS One. 2017;12:e0188799.
    >> Share

  45. LORCA V, Rueda D, Martin-Morales L, Poves C, et al
    Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome.
    PLoS One. 2017;12:e0187312.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016